Objective To conduct a scoping review of models of care for chronic disease management to
identify potentially effective components for management of chronic traumatic brain injury …

Abstract The Spanish Association for the Study of the Liver (AEEH) is convinced that the
elimination of hepatitis C virus (HCV) in Spain is possible as long as we are able to use the …

As direct-acting antiviral (DAA) therapy costs fall and eligibility criteria are relaxed, people
who inject drugs (PWID) will increasingly become eligible for HCV treatment. Yet eligibility …

Background Globally, HCV testing, linkage to care and treatment is sub-optimal among
people who use drugs (PWUD). This study aimed to evaluate the impact of an innovative …

Direct acting antiviral (DAA) treatment has made the elimination of hepatitis C virus (HCV) a
realisable global public health goal and people who inject drugs are a key target population …

Background Although the availability of fully funded direct‐acting antivirals (DAAs) and the
eligibility of primary care providers (PCPs) to provide hepatitis C virus (HCV) have removed …

Achieving hepatitis C virus (HCV) elimination by 2030 requires an increased linkage to care
for people who inject drugs (PWID). Project ITTREAT was established to mitigate barriers to …

Resumen La Asociación Española para el Estudio del Hígado (AEEH) está convencida de
que la eliminación de la hepatitis C en España es posible siempre y cuando seamos …

Introduction The on‐going substance use crisis has led to unprecedented rates of hepatitis
C virus (HCV) in Canada, with increasing positivity among women who use drugs (WWUD) …

Background Barriers to HCV treatment initiation persisted after the introduction of direct-
acting antivirals (DAAs) in Canada among people who inject drugs (PWID); whether DAA …